Valuation DaShenLin Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shanghai S.E. 11/09/2026			5-day change	1st Jan Change
17.70 ^CNY	-1.39%		-5.80%	+0.45%

09-02	Jefferies Adjusts DaShenLin Pharmaceutical Group's Price Target to 15 Yuan From 12 Yuan, Keeps at Underperform	MT
08-24	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	33,307	37,585	28,359	17,151	20,066	20,158	-	-
Change	-	12.85%	-24.55%	-39.52%	17%	0.45%	-	-
Enterprise Value (EV) ¹	32,838	36,233	27,369	15,778	16,831	16,818	16,397	16,102
Change	-	10.34%	-24.46%	-42.35%	6.67%	-0.08%	-2.5%	-1.8%
P/E	42.1x	36.3x	24.2x	18.6x	16.3x	13.6x	11.8x	10.4x
PBR	6.3x	6.24x	4.16x	2.49x	2.72x	2.57x	2.36x	2.19x
PEG	-	1.2x	1.8x	-0.9x	0.5x	0.7x	0.8x	0.8x
Capitalization / Revenue	1.99x	1.77x	1.16x	0.65x	0.73x	0.68x	0.62x	0.56x
EV / Revenue	1.96x	1.71x	1.12x	0.6x	0.61x	0.57x	0.5x	0.45x
EV / EBITDA	13.6x	19.2x	12.9x	4.65x	4.39x	4.39x	3.9x	3.46x
EV / EBIT	31.6x	25.5x	16.8x	10.5x	8.26x	7.24x	6.21x	5.37x
EV / FCF	117x	13.1x	19.7x	9.51x	3.44x	9.75x	5.87x	4.95x
FCF Yield	0.86%	7.61%	5.09%	10.5%	29.1%	10.3%	17%	20.2%
Dividend per Share ²	0.3472	0.5	0.31	0.31	0.49	0.9418	1.043	1.222
Rate of return	1.19%	1.52%	1.24%	2.06%	2.78%	5.32%	5.89%	6.9%
EPS ²	0.6944	0.9083	1.03	0.81	1.08	1.304	1.5	1.701
Distribution rate	50%	55%	30.1%	38.3%	45.4%	72.2%	69.5%	71.8%
Net sales ¹	16,759	21,248	24,531	26,497	27,502	29,540	32,521	35,823
EBITDA ¹	2,408	1,883	2,119	3,395	3,833	3,828	4,204	4,651
EBIT ¹	1,041	1,421	1,632	1,501	2,038	2,324	2,643	2,997
Net income ¹	791.2	1,036	1,166	914.8	1,235	1,486	1,711	1,937
Net Debt ¹	-469.2	-1,352	-989.8	-1,373	-3,236	-3,340	-3,760	-4,056
Reference price ²	29.24	33.00	24.90	15.06	17.62	17.70	17.70	17.70
Nbr of stocks (in thousands)	1,138,968	1,138,947	1,138,902	1,138,848	1,138,848	1,138,855	-	-
Announcement Date	27/04/22	27/04/23	28/04/24	25/04/25	23/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	13.58x	0.57x	4.39x	5.32%	3B
JD HEALTH INTERNATIONAL INC.	15.84x	0.61x	9.13x	-.--%	14.13B
MATSUKIYOCOCOKARA & CO.	16.01x	0.71x	7.45x	2.33%	6.33B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	20.08x	0.75x	12.66x	1.25%	6.22B
YIFENG PHARMACY CHAIN CO., LTD.	14.48x	0.88x	6.19x	2.92%	4.06B
NAHDI MEDICAL COMPANY	14.26x	1.23x	7.5x	5.64%	3.17B
GUARDIAN PHARMACY SERVICES, INC.	35.55x	-	-	-	2.76B
CLICKS GROUP LIMITED	12.92x	0.77x	5.75x	5.03%	2.7B
Average	17.84x	0.79x	7.58x	3.21%	5.3B
Weighted average by Cap.	17.18x	0.73x	8.39x	2.07%